These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31233524)

  • 21. HCV co-infection and markers of liver injury and fibrosis among HIV-positive childbearing women in Ukraine: results from a cohort study.
    Bailey H; Nizova N; Martsynovska V; Volokha A; Malyuta R; Cortina-Borja M; Thorne C;
    BMC Infect Dis; 2016 Dec; 16(1):755. PubMed ID: 27955711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV.
    Liu CJ; Chuang WL; Sheen IS; Wang HY; Chen CY; Tseng KC; Chang TT; Massetto B; Yang JC; Yun C; Knox SJ; Osinusi A; Camus G; Jiang D; Brainard DM; McHutchison JG; Hu TH; Hsu YC; Lo GH; Chu CJ; Chen JJ; Peng CY; Chien RN; Chen PJ
    Gastroenterology; 2018 Mar; 154(4):989-997. PubMed ID: 29174546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants.
    Cooper CL; Read D; Vachon ML; Conway B; Wong A; Ramji A; Borgia S; Tam E; Barrett L; Smyth D; Feld JJ; Lee S;
    BMC Public Health; 2020 Sep; 20(1):1345. PubMed ID: 32883249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Characteristics and Treatment Outcomes of Patients with Hepatitis C Virus and Human Immunodeficiency Virus Coinfection: Experience at a Single Center in Korea.
    Lim DH; Jeong JY; Nam S; Choi J; Kwon HC; Yoon YB; Kim Y; Chin B
    J Korean Med Sci; 2021 Nov; 36(46):e308. PubMed ID: 34845874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HCV disease burden and population segments in Switzerland.
    Bihl F; Bruggmann P; Castro Batänjer E; Dufour JF; Lavanchy D; Müllhaupt B; Negro F; Razavi H; Scheidegger C; Semela D; Semmo N; Blach S
    Liver Int; 2022 Feb; 42(2):330-339. PubMed ID: 34839578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in the epidemiology and distribution of the hepatitis C virus genotypes in North-Eastern Spain over the last 35 years.
    Acero Fernández D; Ferri Iglesias MJ; Buxó Pujolràs M; López Nuñez C; Serra Matamala I; Queralt Molés X; Aldeguer Manté X
    Gastroenterol Hepatol; 2018 Jan; 41(1):2-11. PubMed ID: 29150360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance-associated substitutions in hepatitis C genotype 3 infection.
    von Felden J; Vermehren J; Ingiliz P; Mauss S; Lutz T; Simon KG; Busch HW; Baumgarten A; Schewe K; Hueppe D; Boesecke C; Rockstroh JK; Daeumer M; Luebke N; Timm J; Schulze Zur Wiesch J; Sarrazin C; Christensen S
    Aliment Pharmacol Ther; 2018 May; 47(9):1288-1295. PubMed ID: 29536554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Very Low Hepatitis C Viral Loads in Treatment-naive Persons: Do They Compromise Hepatitis C Virus Antigen Testing?
    Bertisch B; Brezzi M; Negro F; Müllhaupt B; Ottiger C; Künzler-Heule P; Schmid P; Giudici F; Clerc O; Moriggia A; Roelens M; Marinucci F; Zehnder C; Moradpour D; Keiser O;
    Clin Infect Dis; 2020 Feb; 70(4):653-659. PubMed ID: 30943286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation.
    Anthony DD; Sulkowski MS; Smeaton LM; Damjanovska S; Shive CL; Kowal CM; Cohen DE; Bhattacharya D; Alston-Smith BL; Balagopal A; Wyles DL
    J Infect Dis; 2020 Sep; 222(8):1334-1344. PubMed ID: 32406487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology and management of hepatitis C virus infections in immigrant populations.
    Coppola N; Alessio L; Onorato L; Sagnelli C; Macera M; Sagnelli E; Pisaturo M
    Infect Dis Poverty; 2019 Mar; 8(1):17. PubMed ID: 30871599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics and current management of hepatitis B and C in China.
    Sun YT; Zhang YX; Tang H; Mao Q; Wang XZ; Zhang LY; Chen H; Zhong YN; Lin SM; Zhang DZ
    World J Gastroenterol; 2014 Oct; 20(37):13582-90. PubMed ID: 25309089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
    Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA
    Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study.
    Rauch A; Rickenbach M; Weber R; Hirschel B; Tarr PE; Bucher HC; Vernazza P; Bernasconi E; Zinkernagel AS; Evison J; Furrer H;
    Clin Infect Dis; 2005 Aug; 41(3):395-402. PubMed ID: 16007539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis.
    Lim JK; Liapakis AM; Shiffman ML; Lok AS; Zeuzem S; Terrault NA; Park JS; Landis CS; Hassan M; Gallant J; Kuo A; Pockros PJ; Vainorius M; Akushevich L; Michael L; Fried MW; Nelson DR; Ben-Ari Z;
    Clin Gastroenterol Hepatol; 2018 Nov; 16(11):1811-1819.e4. PubMed ID: 29306043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in quality of life, healthcare use, and substance use in HIV/hepatitis C coinfected patients after hepatitis C therapy: a prospective cohort study.
    Yeung MW; Young J; Moodie E; Rollet-Kurhajec KC; Schwartzman K; Greenaway C; Cooper C; Cox J; Gill J; Hull M; Walmsley S; Klein MB
    HIV Clin Trials; 2015; 16(3):100-10. PubMed ID: 25972048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained Virologic Response of Patients Hospitalized Compared With Those Not Hospitalized During Treatment for Hepatitis C Virus With Direct-Acting Antivirals.
    Gentene AJ; Bell AM; Pence A; Thomas K; Jakubecz C; Stacy E; Woolf B; Guido MR; Mueller EW; Sherman KE
    Ann Pharmacother; 2021 May; 55(5):565-574. PubMed ID: 33016095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of hepatitis C in a Swiss sample of men who have sex with men: whom to screen for HCV infection?
    Schmidt AJ; Falcato L; Zahno B; Burri A; Regenass S; Müllhaupt B; Bruggmann P
    BMC Public Health; 2014 Jan; 14():3. PubMed ID: 24393532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral regimen complexity index as an independent predictor of sustained virologic response in patients with chronic hepatitis C.
    Galán RJ; Cidoncha EC; Martin MF; Rodriguez CC; Almeida CV; Verdugo RM
    J Manag Care Pharm; 2013; 19(6):448-53. PubMed ID: 23806058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement of chronic HCV infection-related depression, anxiety, and neurocognitive performance in persons achieving SVR-12: A real-world cohort study.
    Kaur H; Dhiman RK; Kulkarni AV; Premkumar M; Singh V; Duseja AK; Grover S; Grover GS; Roy A; Verma N; De A; Taneja S; Mehtani R; Mishra S; Kaur H
    J Viral Hepat; 2022 May; 29(5):395-406. PubMed ID: 35266624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C virus elimination in Swiss opioid agonist therapy programmes - the SAMMSU cohort.
    Bregenzer A; Bruggmann P; Castro E; Moriggia A; Rothen M; Thurnheer MC; Vernazza P; Scheidegger C
    Swiss Med Wkly; 2021 Mar; 151():w20460. PubMed ID: 33705563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.